Skip to main content

Hoffman William's Form 4 filing

Inari Medical, Inc. (NARI) · filed Jun 8, 2022

Accession no.
0001127602-22-017049
Filed
Jun 8, 2022, 4:28 PM ET
Trade date
Jun 6, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.03M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoffman WilliamCIK 0001304099Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 6, 2022Common StockMOption exerciseAcquired+30,000$0.4284+$12,852580,307Direct
Jun 6, 2022Common StockSSaleDisposed−7,811$67.18−$524,742.98572,496Direct
Jun 6, 2022Common StockSSaleDisposed−21,615$67.97−$1,469,171.55550,881Direct
Jun 6, 2022Common StockSSaleDisposed−574$68.68−$39,422.32550,307Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 6, 2022Common StockMOption exerciseDisposed−30,000$0.00$0320,168Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)